Advertisement MedPodium completes acquisition of US supplement firm - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

MedPodium completes acquisition of US supplement firm

MedPodium, a operating unit of Cardium Therapeutics, has purchased the assets, business and product portfolio of To Go Brands to support the expansion of its health sciences nutraceutical platform.

To Go Brands’ product line includes nutraceutical powder mixes, supplements and chews, which contain 100% natural antioxidant-rich drink mixes with organic ingredients, designed for use in home and capsule-based dietary supplements.

In addition to biotech and pharmaceutical product lines, Cardium has a nutraceutical platform called MedPodium Nutra Apps, which is a line of supplements packaged in single-serving blister packs targeted primarily at Gen Y consumers.

Cardium CEO Christopher Reinhard said the acquisition of To Go Brands is focused on building its MedPodium in-house brand platform and health sciences business.

"To Go Brands have an established brand, a portfolio of marketed products, established logistics and distribution capabilities, a website e-commerce platform, and an experienced management team with key contacts and a track record of developing and placing new and innovative health and nutraceutical products into the mass, food and drug retail channels," Reinhard added.

"To Go Brands will coordinate Cardium’s health sciences brand platform, including the MedPodium Nutra-Apps® product line, as well as our strategic investment in SourceOne Global Partners, a leading supplier of science-based ingredients and proprietary formulas to the national supplement and functional food and beverage industries.

"According to a new industry report, U.S. supplement sales are estimated to total $11.5 billion in 2012 and are projected to reach $15.5 billion by 2017."